OBM Geriatrics is an Open Access journal published quarterly online by LIDSEN Publishing Inc. The journal takes the premise that innovative approaches – including gene therapy, cell therapy, and epigenetic modulation – will result in clinical interventions that alter the fundamental pathology and the clinical course of age-related human diseases. We will give strong preference to papers that emphasize an alteration (or a potential alteration) in the fundamental disease course of Alzheimer’s disease, vascular aging diseases, osteoarthritis, osteoporosis, skin aging, immune senescence, and other age-related diseases.
Geriatric medicine is now entering a unique point in history, where the focus will no longer be on palliative, ameliorative, or social aspects of care for age-related disease, but will be capable of stopping, preventing, and reversing major disease constellations that have heretofore been entirely resistant to interventions based on “small molecular” pharmacological approaches. With the changing emphasis from genetic to epigenetic understandings of pathology (including telomere biology), with the use of gene delivery systems (including viral delivery systems), and with the use of cell-based therapies (including stem cell therapies), a fatalistic view of age-related disease is no longer a reasonable clinical default nor an appropriate clinical research paradigm.
Precedence will be given to papers describing fundamental interventions, including interventions that affect cell senescence, patterns of gene expression, telomere biology, stem cell biology, and other innovative, 21st century interventions, especially if the focus is on clinical applications, ongoing clinical trials, or animal trials preparatory to phase 1 human clinical trials.
Papers must be clear and concise, but detailed data is strongly encouraged. The journal publishes research articles, reviews, communications and technical notes. There is no restriction on the length of the papers and we encourage scientists to publish their results in as much detail as possible.
Ageing and a Biopsychosocial Approach
Submission Deadline: June 20, 2019 (Open) Submit Now
Donatella R. Petretto
Professor, Section on Clinical Psychology, Department of Education, Psychology, Philosophy, University of Cagliari, Cagliari, Italy
E-Mail: [email protected]
Research Interests: Active ageing; successful ageing; oldest old; cognitive functioning; well-being; partecipation; disability; health and disablement
President, Worldwide Community on Longevity, Assemini, Italy
E-Mail: [email protected]
Research Interest: Active ageing; genetics; successful ageing; biopsychosocial approach; microbiome
About This Topic
Ageing is a complex phenomenon, related to genetics, constitutional variables, life styles and environmental variables (Pili & Petretto, 2017). The awareness that we are in a special period of progressive ageing of population has led researchers to focus attention on this complex phenomenon, aiming to develop interventions to promote wellbeing and quality of life of ageing people, to prevent and control age-related disorders and diseases and also aiming to help society as a whole to comprehend that the progressive ageing of populations is not merely a negative process nor a positive process. Aiming to control this process, a multidisciplinary approach is needed and an integration between knowledge from the biological and medical aspects of ageing, from the psychological aspects and the social aspects is also needed.
The aim of the Special Issue is to propose a biopsychosocial approach to ageing and to discuss how to integrate knowledge from different fields of study. Last but not least, the aim of the Special Issue is also to propose some critical hints in the analysis of this field.